Neumora Therapeutics NMRA
NASDAQ NMRA
$0.38 -0.03 (-7.32%)
At close: Oct 23, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Sale and Maturity of Investments (2022 - 2025)

Updated

Analysis

Neumora Therapeutics (NMRA) Sale and Maturity of Investments (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Neumora Therapeutics 71.40 Mn -546.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 42.58 Mn
Sep 30, 2025 51.25 Mn
Jun 30, 2025 68.80 Mn
Mar 31, 2025 88.55 Mn
Dec 31, 2024 8.10 Mn
Sep 30, 2024 156.97 Mn
Jun 30, 2024 40.79 Mn
Mar 31, 2024 36.58 Mn
Dec 31, 2023 38.38 Mn
Sep 30, 2023 36.71 Mn
Jun 30, 2023 58.74 Mn
Mar 31, 2023 44.34 Mn
Dec 31, 2022 40.09 Mn
API Access

Neumora Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=NMRA&period=max&api_key=YOUR_API_KEY